Myron J Levin Selected Research

Varicella Zoster Virus Infection

1/2019	Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.
11/2017	Cytokines Produced in Response to Varicella-Zoster Virus Infection of ARPE-19 Cells Stimulate Lymphocyte Chemotaxis.
8/2016	Incidence and consequences of varicella in children treated for cancer in Guatemala.
10/2011	Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Myron J Levin Research Topics

Disease

53	Herpes Zoster 11/2023 - 10/2003
22	Infections 01/2023 - 06/2003
12	Human Influenza (Influenza) 12/2023 - 08/2008
11	Chickenpox 01/2023 - 10/2003
11	Pain (Aches) 11/2022 - 08/2004
8	Postherpetic Neuralgia 01/2020 - 08/2004
6	COVID-19 05/2024 - 01/2022
5	Exanthema (Rash) 10/2020 - 08/2004
5	Neoplasms (Cancer) 01/2020 - 10/2003
4	Varicella Zoster Virus Infection 01/2019 - 10/2011
4	HIV Infections (HIV Infection) 01/2017 - 08/2008
3	Herpes Simplex 01/2014 - 04/2011
2	Frailty 01/2021 - 01/2019
2	Measles 10/2019 - 08/2012
2	Mumps 10/2019 - 08/2012
2	Rubella (German Measles) 10/2019 - 08/2012
2	Virus Diseases (Viral Diseases) 01/2019 - 07/2015
2	Inflammation (Inflammations) 01/2018 - 01/2017
2	Leukemia 08/2016 - 03/2008
2	Uterine Cervical Dysplasia 05/2016 - 12/2014
2	Thrombocytopenia (Thrombopenia) 01/2016 - 01/2015
2	Viremia 01/2016 - 05/2005
2	Neutropenia 01/2016 - 01/2015
2	Anemia 01/2016 - 01/2015
2	Adenoviridae Infections (Adenovirus Infections) 07/2015 - 12/2005
2	Herpesviridae Infections (Herpesvirus Infection) 07/2015 - 01/2003
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2014 - 10/2009
2	Persistent Infection 12/2014 - 10/2003
2	Herpes Labialis (Fever Blister) 04/2011 - 04/2003
2	Injection Site Reaction 10/2009 - 03/2008
1	Severe Acute Respiratory Syndrome 05/2024
1	Breakthrough Infections 10/2023
1	COVID-19 breakthrough infections 10/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Lymphocytosis 01/2022
1	Pneumococcal Pneumonia 01/2021
1	Pneumococcal Infections 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Serum Sickness 01/2019
1	Posterior Uveitis 11/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2017
1	Papillomavirus Infections 05/2016
1	AIDS-Related Opportunistic Infections 12/2015
1	Hyperbilirubinemia 01/2015

Drug/Important Bio-Agent (IBA)

59	VaccinesIBA 11/2023 - 06/2001
20	Herpes Zoster VaccineIBA 11/2022 - 09/2007
8	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2023 - 08/2008
8	Antiviral Agents (Antivirals)IBA 08/2016 - 11/2004
7	Chickenpox Vaccine (Vaccine, Varicella)IBA 01/2023 - 02/2007
5	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 06/2003
5	Subunit VaccinesIBA 01/2018 - 01/2012
4	cilgavimabIBA 05/2024 - 01/2022
4	cilgavimab and tixagevimab drug combinationIBA 05/2024 - 01/2022
4	tixagevimabIBA 05/2024 - 01/2022
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2017
4	AntibodiesIBA 01/2012 - 04/2005
3	Glycoproteins (Glycoprotein)IBA 01/2021 - 01/2012
3	Inactivated VaccinesIBA 08/2016 - 01/2010
3	Papillomavirus Vaccines (HPV Vaccines)IBA 05/2016 - 10/2010
3	EnzymesIBA 01/2016 - 05/2005
3	NucleosidesIBA 07/2015 - 04/2003
3	Acyclovir (Aciclovir)FDA LinkGeneric 04/2011 - 01/2003
3	RNA (Ribonucleic Acid)IBA 11/2007 - 10/2004
2	Proteins (Proteins, Gene)FDA Link 10/2023 - 05/2005
2	Immunoglobulin G (IgG)IBA 01/2021 - 12/2009
2	varicella-zoster immune globulin (VZIG)IBA 09/2020 - 01/2019
2	varicella-zoster virus glycoprotein EIBA 01/2018 - 09/2016
2	AS01B adjuvantIBA 01/2018 - 09/2016
2	Rotavirus VaccinesIBA 01/2017 - 01/2017
2	Immunoglobulin A (IgA)IBA 01/2017 - 12/2009
2	RotaTeqIBA 01/2017 - 01/2017
2	Cidofovir (Vistide)FDA Link 07/2015 - 12/2005
2	AntigensIBA 01/2012 - 11/2007
2	18 16 11 Types 6 Human Papillomavirus Recombinant Vaccine Quadrivalent (Gardasil)FDA Link 10/2011 - 10/2009
2	18 L1 type 16 human papillomavirus vaccine (Cervarix)IBA 10/2011 - 10/2009
2	penciclovir (Denavir)FDA Link 04/2003 - 01/2003
1	mRNA VaccinesIBA 12/2023
1	TEMPOIBA 01/2023
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2021
1	Attenuated VaccinesIBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2021
1	zonulinIBA 01/2018
1	CytokinesIBA 11/2017
1	Illicit Drugs (Recreational Drugs)IBA 01/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2015
1	Stavudine (Zerit)FDA LinkGeneric 01/2015
1	Alanine Transaminase (SGPT)IBA 01/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2015
1	Lamivudine (Epivir)FDA Link 01/2015

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2003
6	Highly Active Antiretroviral Therapy (HAART) 12/2018 - 11/2007
5	Activities of Daily Living (ADL) 01/2020 - 08/2004
2	Drug Therapy (Chemotherapy) 01/2020 - 08/2016
2	Hematopoietic Stem Cell Transplantation 07/2015 - 12/2005
1	Intramuscular Injections 01/2023
1	Critical Care (Surgical Intensive Care) 08/2016
1	Ambulatory Care (Outpatient Care) 04/2016